Validation of Four Triple Negative Breast Cancer-Specific Genes and their Association with Prognosis

被引：0
|
作者：
Pariyar, M. [1 ,2 ]
Scott, R. [1 ,2 ,3 ]
Avery-Kiejda, K. [1 ,2 ]
机构：
[1] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Canc Res Innovat & Translat, Callaghan, NSW, Australia
[2] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] John Hunter Hosp, Pathol NORTH, New Lambton Hts, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OR20
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [41] Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1
    Ren, Yi
    Deng, Rong
    Zhang, Qian
    Li, Jing
    Han, Baosan
    Ye, Ping
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [42] Mutation spectrum of homologous recombination repair genes in early triple-negative breast cancer: association with clinicopathological factors, immune infiltration, and prognosis
    Lu, Y.
    Wang, Z.
    Han, M.
    Li, A.
    Ruan, M.
    Wang, C.
    Zhang, X.
    Zhu, C.
    Shen, K.
    Chen, X.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 101 - 101
  • [43] HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer
    Ma, Youzhao
    Jiao, Dechuang
    Zhang, Jingyang
    Lv, Minhao
    Chen, Xiuchun
    Liu, Zhenzhen
    ONCOLOGIST, 2024, 29 (03): : E309 - E318
  • [44] The Prognosis of Metaplastic Breast Cancer Patients Compare to Triple-Negative Breast Cancer Patients
    Cho, D. H.
    Jang, J. H.
    Lee, S. K.
    Choi, M-Y
    Koo, M. Y.
    Hur, S. M.
    Bae, S. Y.
    Kim, S. M.
    Choe, J-H
    Lee, J. E.
    Kim, J-H
    Kim, J. S.
    Nam, S. J.
    Yang, J-H
    CANCER RESEARCH, 2010, 70
  • [45] Clinical Significance of Past History of Breast Cancer Screening for the Prognosis of Triple Negative Breast Cancer
    Inoue, Shingo
    Kawaida, Hiromichi
    Saito, Ryo
    Nakayama, Yuko
    Ohmori, Masato
    Kimura, Ayako
    Shoda, Katsutoshi
    Furuya, Shinji
    Hosomura, Naohiro
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Amemiya, Hidetake
    Sudo, Makoto
    Kono, Hiroshi
    Ichikawa, Daisuke
    ANTICANCER RESEARCH, 2021, 41 (02) : 1077 - 1082
  • [46] Prognosis of Metaplastic Breast Cancer: Poorer Than the Rest of Triple-Negative Breast Cancer
    Jung, S-Y
    Kim, H. Y.
    Min, S. Y.
    Lee, S. J.
    Park, C.
    Kwon, Y.
    Kim, E-A
    Ko, K. L.
    Lee, K. S.
    Park, I. H.
    Shin, K. H.
    Lee, S.
    Kim, S. W.
    Kang, H-S
    Ro, J.
    CANCER RESEARCH, 2009, 69 (24) : 725S - 726S
  • [47] Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
    Guo, Yangyang
    Cen, Kenan
    Yang, Shi
    Mai, Yifeng
    Hong, Kai
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
    Patel, Nirmesh
    Weekes, Daniel
    Drosopoulos, Konstantinos
    Gazinska, Patrycja
    Noel, Elodie
    Rashid, Mamun
    Mirza, Hasan
    Quist, Jelmar
    Braso-Maristany, Fara
    Mathew, Sumi
    Ferro, Riccardo
    Pereira, Ana Mendes
    Prince, Cynthia
    Noor, Farzana
    Francesch-Domenech, Erika
    Marlow, Rebecca
    de Rinaldis, Emanuele
    Grigoriadis, Anita
    Linardopoulos, Spiros
    Marra, Pierfrancesco
    Tutt, Andrew N. J.
    NATURE COMMUNICATIONS, 2018, 9
  • [49] Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality
    Lin, Shuhuang
    Wang, Zhuo
    Xing, Mingzhao
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (05): : 1222 - 1230
  • [50] CLINICAL PREDICTION FACTORS OF PROGNOSIS IN OPERABLE TRIPLE NEGATIVE BREAST CANCER
    Turk, M.
    Sobocan, M.
    Cater, P.
    Sikosek, N. Cas
    Crnobrnja, B.
    Arko, D.
    Takac, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A189 - A189
12345